Finzati - Logo
INKT logo

MiNK Therapeutics, Inc.

INKTBiotechnology
$11.64
+0.41 (+3.65%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$58.47M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:29 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$11.64
Change3.65%
Shares Out5.02M
Market Cap$58.47M
Enterprise Value$-8.75B
52W Range8.48 - 18.17
Beta0.48
P/E-0.02
P/FCF-0.02
EV/EBITDA1,060.89
EV/FCF2.29
Dividend Yield0.00%

Investment DNA

How strong this company looks for long-term investors

31
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
46/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score
Weak profitability

Analyst view

Analyst sentiment and price target

INKT
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
90/100
Bullish
Bullish
4
Hold
1
Bearish
0
Price Target
2026-08-14
Low
$35.00
Mean
$35.00
Median
$35.00
High
$35.00

Company Overview

IPO: 10/15/2021
Industry: Biotechnology
P/B i: -3.35
Debt / Equity i: -0.36
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score9 / 20
Debt / Equity: -0.36
Current Ratio: 1.06
Quick Ratio: 1.06
Status: Moderate

Insider Transactions

Recent executive and insider activity

Ryan Barbara
Transaction: 06/04/2026
SELL
Change
-1,000
Price
$12.80
Filing
06/05/2026
Type
SELL
WIINBERG ULF
Transaction: 06/01/2026
BUY
Change
+1,131
Price
$12.38
Filing
06/02/2026
Type
BUY
Behner Peter
Transaction: 06/01/2026
BUY
Change
+1,313
Price
$12.38
Filing
06/02/2026
Type
BUY